A total of 9 abstracts presented at the 18th Annual European Neuroendocrine Tumor Society (ENETS) Conference showcasing new data across the patient pathway in neuroendocrine tumors Latest data from ...
Phase IIb randomized trial of JX-594, a targeted multimechanistic oncolytic vaccinia virus, plus best supportive care (BSC) versus BSC alone in patients with advanced hepatocellular carcinoma who have ...
Neuroendocrine tumours (NETs) are rare, and patients are typically diagnosed with inoperable disease or distant metastases. Moreover, few approved treatment options with antiproliferative efficacy ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback